AOD 9604 + NAD+ Combining AOD 9604 with NAD+ therapy at Perfect B in Doral targets two separate axes of metabolic function: NAD+ addresses cellular energy metabolism, mitochondrial efficiency, and metabolic resilience at the enzymatic level, while AOD 9604 drives fat mobilization from adipose tissue
Nothing on this site is intended for human or animal use, including therapeutic, diagnostic, clinical, veterinary, or personal applications
Topical GHK-Cu: Patient Perspectives The distinction between injectable and non-injectable GHK-Cu matters because different patient populations use different routes: Topical GHK-Cu Users Licensed Healthcare Practitioners 1,000+ physician-grade products, bulk-tier pricing, and direct shipping to your practice
Discussion 1) The study by Tukhovskaya et al investigated the impact of intranasal DSIP on motor function recovery and brain infarction volume in SD rats subjected to focal stroke induced by MCAO